Company Information

Location

Cambridge, MA

CEO

John Quisel, JD, PhD

Website

www.discmedicine.com

Social

LinkedIn

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercialising novel treatments for patients who suffer from serious haematological diseases. They are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of haematological diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.

Latest Updates